Proton Radiotherapy May Be Feasible Option for Pediatric Brain Tumor
Proton radiotherapy showed acceptable toxicity and similar survival compared to conventional radiotherapy.
Proton radiotherapy showed acceptable toxicity and similar survival compared to conventional radiotherapy.
The association may be mediated by mechanisms dependent on matrix metalloproteinases.
The device is designed to measure pressure and temperature during and after surgery, and then dissolve. Human trials are still at least 3 to 4 years away, however.
Two years post-enrollment, 43% of patients in the combination therapy group were alive.
The adaptive trial design will allow GBM patients to benefit from precision medicine.
Researchers found that brain tumor mutations could be detected from ctDNA in cerebrospinal fluid.
Resecting more than just the tuber may help prolong seizure freedom in patients with TSC.
The device may now be used to treat newly-diagnosed patients in combination with temozolomide.
A reduction primarily in grey matter and expansion of the brain’s ventricles was observed.
Researchers found an association between obesity and meningioma risk, but not for glioma.